SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (530)7/21/1999 3:17:00 PM
From: Mike McFarland  Read Replies (1) of 4474
 
Src-homology domains
hms.harvard.edu

I have not yet found that Ariad has any agreements
with this lab.

Last year's Mid-Year report to shareholders mentioned
AP22408--designed to directly block src, but I do not
remember seeing anything since that time.

Does anybody have a feel for how the Harvard
nanodroplet technology might be used?

It's funny...although I readily admit to very
marginal comprehension of what I read in the
various journal articles, or for that matter the
basic science in my Cell textbook, I still feel
compelled to put my bet on this horse.

Of course I am reminded of the time at the track--
with each race I put a bet on the nicest looking horse,
the prettiest, the leanest. I did not pick any fast
horses that day, but had great fun anyway.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News